HTLV-1 drives vigorous clonal expansion of infected CD8+ T cells in natural infection
Open Access
- 9 November 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Retrovirology
- Vol. 12 (1), 1-10
- https://doi.org/10.1186/s12977-015-0221-1
Abstract
Human T-lymphotropic Virus Type I (HTLV-1) is a retrovirus that persistently infects 5–10 million individuals worldwide and causes disabling or fatal inflammatory and malignant diseases. The majority of the HTLV-1 proviral load is found in CD4+ T cells, and the phenotype of adult T cell leukemia (ATL) is typically CD4+. HTLV-1 also infects CD8+ cells in vivo, but the relative abundance and clonal composition of the two infected subpopulations have not been studied. We used a high-throughput DNA sequencing protocol to map and quantify HTLV-1 proviral integration sites in separated populations of CD4+ cells, CD8+ cells and unsorted peripheral blood mononuclear cells from 12 HTLV-1-infected individuals. We show that the infected CD8+ cells constitute a median of 5 % of the HTLV-1 proviral load. However, HTLV-1-infected CD8+ clones undergo much greater oligoclonal proliferation than the infected CD4+ clones in infected individuals, regardless of disease manifestation. The CD8+ clones are over-represented among the most abundant clones in the blood and are redetected even after several years. We conclude that although they make up only 5 % of the proviral load, the HTLV-1-infected CD8+ T-cells make a major impact on the clonal composition of HTLV-1-infected cells in the blood. The greater degree of oligoclonal expansion observed in the infected CD8+ T cells, contrasts with the CD4+ phenotype of ATL; cases of CD8+ adult T-cell leukaemia/lymphoma are rare. This work is consistent with growing evidence that oligoclonal expansion of HTLV-1-infected cells is not sufficient for malignant transformation.Keywords
Funding Information
- Wellcome Trust (GB) (100291)
- NIHR Imperial Biomedical Research Centre
This publication has 49 references indexed in Scilit:
- Massive Depletion of Bovine Leukemia Virus Proviral Clones Located in Genomic Transcriptionally Active Sites during Primary InfectionPLoS Pathogens, 2013
- Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivoPLoS Pathogens, 2013
- Genome-wide Determinants of Proviral Targeting, Clonal Abundance and Expression in Natural HTLV-1 InfectionPLoS Pathogens, 2013
- HTLV-1–infected T cells contain a single integrated provirus in natural infectionBlood, 2012
- Distinct Transformation Tropism Exhibited by Human T Lymphotropic Virus Type 1 (HTLV-1) and HTLV-2 Is the Result of Postinfection T Cell Clonal ExpansionJournal of Virology, 2012
- The host genomic environment of the provirus determines the abundance of HTLV-1–infected T-cell clonesBlood, 2011
- In vivo Expression of Human T-lymphotropic Virus Type 1 Basic Leucine-Zipper Protein Generates Specific CD8+ and CD4+ T-Lymphocyte Responses that Correlate with Clinical OutcomeThe Journal of Infectious Diseases, 2011
- Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus MeetingJournal of Clinical Oncology, 2009
- Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 Use Different Receptor Complexes To Enter T CellsJournal of Virology, 2006
- HTLV-1 propels untransformed CD4+ lymphocytes into the cell cycle while protecting CD8+ cells from deathJCI Insight, 2006